C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2009
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009	CN101610997A Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/23/2009	CN101610996A Inhibitors of histone deacetylase and prodrugs thereof
12/23/2009	CN101610995A Novel antagonists of the glucagon receptor
12/22/2009	CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009	CA2324117C Process for preparing a noncrystallizable polyol syrup
12/17/2009	WO2009149807A1 Fluorosurfactants
12/17/2009	WO2009106361A3 Inhibitors of cell proliferation and uses thereof
12/17/2009	WO2009092590A3 2 -cyano phenyl sulfonamide derivatives useful as pesticides
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312328 Sulfonamide compound or salt thereof
12/16/2009	EP2132174A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
12/16/2009	EP2132169A1 New methylenebisphenyl compounds useful in the treatment of inflammation
12/16/2009	EP1737812B1 Methods of amination
12/16/2009	CN100569745C Method of preparing tamsulosin
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009	CA2525854C Acylsulfamide inhibitors of factor viia
12/10/2009	WO2009148600A2 Deuterated lysine-based compounds
12/10/2009	WO2009148052A1 Sulfonamide compound and application thereof
12/10/2009	WO2009147632A2 New compounds for the treatment of cancer
12/10/2009	WO2009146871A1 5-lipoxygenase inhibitors
12/10/2009	WO2008152333A9 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/10/2009	US20090306428 Process for the Synthesis of C-2, C-3 Substituted N-Alkylated Indoles Useful as cPLA2 Inhibitors
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	CA2726610A1 Sulfonamide compounds and use thereof
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	CN101597246A Preparation method of 2-(3, 3, 3-trifluoro propyl) benzsulfamide (I) and midbody thereof
12/08/2009	US7629492 Halo active aromatic sulfonamide organic compounds and odor control uses therefor
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629298 Sandstone having a modified wettability and a method for modifying the surface energy of sandstone
12/03/2009	WO2009145989A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors
12/03/2009	WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009	US20090299066 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/03/2009	US20090298898 Pesticidally active ketone and oxime derivatives
12/03/2009	CA2729812A1 Therapeutic agent for alzheimer's disease
12/02/2009	EP2125718A2 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
12/02/2009	CN101595088A Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
12/02/2009	CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009	CN101591327A Benzene alkyl amides compound and usage thereof
12/02/2009	CN101591296A High-density ionic liquid and preparation method thereof
12/02/2009	CN101591276A Method for preparing bumetanide
12/02/2009	CN101591275A Method for synthesizing 1,6-eneyne compounds
12/01/2009	US7626033 Compounds for the modulation of PPARγ activity
12/01/2009	US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
11/2009
11/26/2009	WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009	WO2009087085A3 Ortho-substituted cyano (hetero)aryl sulfonyl compounds with pesticidal activity
11/26/2009	WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer
11/26/2009	US20090291978 Enzyme Inhibitors
11/26/2009	CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/25/2009	EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009	EP2121590A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/25/2009	EP2121589A2 Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease
11/25/2009	EP1638924B1 Pesticidally active ketone and oxime derivatives
11/25/2009	EP1375478B1 Process for preparing amino compounds by using salen-manganese complexes as the catalyst
11/25/2009	CN101585788A Allyl sulfonamides compound, preparation method and application thereof
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009	CN100562511C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/24/2009	US7622501 Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
11/24/2009	US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009	CA2418794C Calcium receptor antagonists
11/24/2009	CA2389378C 20-hete synthase inhibitor
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009	WO2009138758A2 Bis-aryl compounds for use as medicaments
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009	US20090286713 Collagen Receptor I-Domain Binding Modulators
11/18/2009	EP2119700A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
11/18/2009	EP2119699A1 Process for preparing acylsulfamoylbenzamides
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/17/2009	US7619116 Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
11/17/2009	US7619115 Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	US7618955 Association of an antithrombotic and aspirin
11/17/2009	CA2266643C Ionic compounds with delocalized anionic charge, their use as components of ionic conductors or catalyst
11/12/2009	WO2009136617A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/12/2009	WO2009136608A1 Ionic liquid
11/12/2009	US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009	CA2723133A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/11/2009	EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009	EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009	EP1557407B1 Novel alpha-ketoamide derivatives and use thereof
11/11/2009	CN101578263A Sulfonamides and their use as a medicament
11/11/2009	CN101578262A Radiolabelling via fluorination of aziridines
11/11/2009	CN101575306A Method for preparing sivelestat sodium
11/11/2009	CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009	US7615514 Pre-emergence and post-emergence selective herbicidal compositions comprising an active compound combination consisting of substituted arylsulphonylaminocarbonyl-triazolinones and/or salts thereof and at least one compound which improves crop plant compatibility
11/10/2009	CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009	CA2378782C Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate
11/05/2009	US20090275659 Phenyl acetic acid derivatives as inflammation modulators
11/05/2009	US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009	US20090275064 Methods to identify therapeutic agents
11/04/2009	EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009	EP1339684B1 Mch antagonists and their use in the treatment of obesity

1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 177